Article

Retinal assessment made easy by digital imaging

Wakeforest, NC-Digital Healthcare Inc. has received FDA approval to pre-market its retinal risk assessment system (Retasure) and its iP technology platform.

Wakeforest, NC-Digital Healthcare Inc. has received FDA approval to pre-market its retinal risk assessment system (Retasure) and its iP technology platform.

Primary-care physicians now can capture digital images of diabetic patients' retinas in a non-invasive procedure. The digital images are transmitted over a secure, HIPPA-compliant network to a board-certified ophthalmologist at an accredited reading center for examination and assessment.

Seven major contracts with primary diabetes care and ophthalmology providers have already been announced, and general availability throughout the United States is being planned.

This system is unique because it can be operated by non-clinicians; it's non-invasive and requires no dilation; it obtains high-quality digital images of the retina; it returns results quickly to primary-care physicians; and it encourages patient compliance for regular retinal assessment, according to Digital Healthcare.

Related Videos
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) World Cornea Congress IX: Epi-on and accelerated crosslinking with Kenneth Beckman, MD
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Development and evaluation of an AI model to set target IOP with Jithin Yohannan, MD, MPH
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
© 2025 MJH Life Sciences

All rights reserved.